The trajectory of companies tied to iconic drugs like Viagra presents a challenging investment picture. While the initial rise of copyright, fueled by Viagra's remarkable popularity, generated substantial wealth , the patent expiration in key territories has introduced significant risk . Investors are now assessing the consequences of generic compe